Skip to main content

ZITUVIMET XR

Generic: sitagliptin and metformin hydrochloride

Verified·Apr 23, 2026
Manufacturer
Zydus
NDC
70771-1879
RxCUI
1243827
Route
ORAL
ICD-10 indication
E11.9

Affordability Check

How much will you actually pay for ZITUVIMET XR?

In 30 seconds, see every legitimate way to afford ZITUVIMET XR — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About ZITUVIMET XR

What is this medication? ZITUVIMET XR is a prescription medication that combines two different anti-diabetic ingredients, sitagliptin and metformin hydrochloride extended-release, into one tablet. It is specifically used to help lower blood sugar levels in adults with type 2 diabetes mellitus when used alongside a proper diet and exercise program. By combining these two medications, it helps patients manage their condition with fewer individual pills while providing a steady release of metformin throughout the day.

The two components of this medication work together to improve glycemic control through different mechanisms. Sitagliptin helps the pancreas produce more insulin and lowers the amount of sugar produced by the liver, while metformin helps the body respond better to its own insulin and decreases the amount of sugar absorbed from food. This treatment is not intended for individuals with type 1 diabetes or those suffering from diabetic ketoacidosis, and it should only be used under the guidance of a healthcare provider.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How ZITUVIMET XR appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

0%

25 of 5,509 plans

Most common tier

Tier 1

On 67% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)2
67%
Tier 3 (preferred brand)1
33%

Step therapy: 0% of formularies

Quantity limits: 100% of formularies

Coverage breadth: 3 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.